Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
J.A Soto, N.M.S Galvez, D.B Rivera, F.E Díaz, C.A Riedel, S.M Bueno & A.M Kalergis. (2022) From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection. Expert Opinion on Drug Discovery 17:11, pages 1237-1259.
Read now
Read now
Ashok Aspatwar, Wenping Gong, Shuyong Wang, Xueqiong Wu & Seppo Parkkila. (2022) Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic. International Reviews of Immunology 41:2, pages 283-296.
Read now
Read now
Seyhan Boyoglu-Barnum & Ralph A. Tripp. (2020) Up-to-date role of biologics in the management of respiratory syncytial virus. Expert Opinion on Biological Therapy 20:9, pages 1073-1082.
Read now
Read now
Natalia Muñoz-Durango, Magdalena S. Pizarro-Ortega, Emma Rey-Jurado, Fabián E. Díaz, Susan M. Bueno & Alexis M. Kalergis. (2018) Patterns of antibody response during natural hRSV infection: insights for the development of new antibody-based therapies. Expert Opinion on Investigational Drugs 27:9, pages 721-731.
Read now
Read now
Articles from other publishers (15)
Carlyn Monèt Guthrie, Xuejuan Tan, Amber Cherry Meeker, Ashton Elisabeth Self, Lin Liu & Yong Cheng. (2023) Engineering a dual vaccine against COVID-19 and tuberculosis. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Shifa Bushra Kotwal, Nidhi Orekondey, Gargi Prasad Saradadevi, Neha Priyadarshini, Navinchandra V. Puppala, Mahak Bhushan, Snehasri Motamarry, Rahul Kumar, Gireesha Mohannath & Ruchi Jain Dey. (2023) Multidimensional futuristic approaches to address the pandemics beyond COVID-19. Heliyon 9:6, pages e17148.
Crossref
Crossref
Jingli Du, Yue Su, Ruilan Wang, Enjun Dong, Yan Cao, Wenjuan Zhao & Wenping Gong. (2023) Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19. Frontiers in Immunology 14.
Crossref
Crossref
Consuelo E. Covarrubias, Thomas A. Rivera, Catalina A. Soto, Trevor Deeks & Alexis M. Kalergis. (2022) Current GMP standards for the production of vaccines and antibodies: An overview. Frontiers in Public Health 10.
Crossref
Crossref
Wansheng Peng, Lian Wang, Hui Zhang, Zhen Zhang & Xin Chen. (2021) Effects of Recombinant IL-35-BCG on Treg/Th17 Cell Imbalance and Inflammatory Response in Asthmatic Newborn Mice Induced by RSV. Inflammation 44:6, pages 2476-2485.
Crossref
Crossref
Fabián E. Díaz, Mariana Guerra-Maupome, Paiton O. McDonald, Daniela Rivera-Pérez, Alexis M. Kalergis & Jodi L. McGill. (2021) A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus. Frontiers in Immunology 12.
Crossref
Crossref
Maria Gonzalez-Perez, Rodrigo Sanchez-Tarjuelo, Boris Shor, Estanislao Nistal-Villan & Jordi Ochando. (2021) The BCG Vaccine for COVID-19: First Verdict and Future Directions. Frontiers in Immunology 12.
Crossref
Crossref
Joseph B. Domachowske, Evan J. Anderson & Mitchell Goldstein. (2021) The Future of Respiratory Syncytial Virus Disease Prevention and Treatment. Infectious Diseases and Therapy 10:S1, pages 47-60.
Crossref
Crossref
Camila Covián, Mariana Ríos, Roslye V. Berríos-Rojas, Susan M. Bueno & Alexis M. Kalergis. (2021) Induction of Trained Immunity by Recombinant Vaccines. Frontiers in Immunology 11.
Crossref
Crossref
Prasanta Raghab Mohapatra, Baijayantimala Mishra & Bijayini Behera. (2021) BCG vaccination induced protection from COVID-19. Indian Journal of Tuberculosis 68:1, pages 119-124.
Crossref
Crossref
Kiddus Yitbarek, Gelila Abraham, Tsinuel Girma, Tizta Tilahun & Mirkuzie Woldie. (2020) The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Vaccine 38:41, pages 6374-6380.
Crossref
Crossref
Yaneisi Vázquez, Liliana González, Loreani Noguera, Pablo A. González, Claudia A. Riedel, Pablo Bertrand & Susan M. Bueno. (2019) Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update. Frontiers in Immunology 10.
Crossref
Crossref
Sofia S. Aranda & Fernando P. Polack. (2019) Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade. Frontiers in Immunology 10.
Crossref
Crossref
Eduardo I. Tognarelli, Susan M. Bueno & Pablo A. González. (2019) Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells. Frontiers in Immunology 10.
Crossref
Crossref
Natalie I Mazur, Deborah Higgins, Marta C Nunes, José A Melero, Annefleur C Langedijk, Nicole Horsley, Ursula J Buchholz, Peter J Openshaw, Jason S McLellan, Janet A Englund, Asuncion Mejias, Ruth A Karron, Eric AF Simões, Ivana Knezevic, Octavio Ramilo, Pedro A Piedra, Helen Y Chu, Ann R Falsey, Harish Nair, Leyla Kragten-Tabatabaie, Anne Greenough, Eugenio Baraldi, Nikolaos G Papadopoulos, Johan Vekemans, Fernando P Polack, Mair Powell, Ashish Satav, Edward E Walsh, Renato T Stein, Barney S Graham & Louis J Bont. (2018) The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. The Lancet Infectious Diseases 18:10, pages e295-e311.
Crossref
Crossref